SCHEMBL7467304

SCHEMBL7467304

COCCOc1c(OC)cc(C=O)cc1OC

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FDPS P14324 2/20 0.57
TNFRSF1A P19438 1/20 0.57
ALDH1A1 P00352 11/20 0.49
MAPK1 P28482 2/20 0.49
TSHR P16473 1/20 0.47
MAPT P10636 8/20 0.47
LMNA P02545 2/20 0.47
HTT P42858 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
HPGD P15428 5/20 0.44
TDP1 Q9NUW8 3/20 0.44
L3MBTL1 Q9Y468 3/20 0.44
POLB P06746 2/20 0.44
MEN1 O00255 1/20 0.44
ALOX12 P18054 1/20 0.44
RECQL P46063 1/20 0.44
KMT2A Q03164 1/20 0.44
PDCD1 Q15116 1/20 0.43
CD274 Q9NZQ7 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6943688 0.89 ALDH1A1 (0.64) FDPSTNFRSF1AALDH1A1MAPK1TSHR
SCHEMBL16680535 0.89 FDPS (0.50) FDPSTNFRSF1AALDH1A1MAPK1TSHR
SCHEMBL6739941 0.87 FDPS (0.54) FDPSTNFRSF1AALDH1A1MAPK1TSHR
SCHEMBL8615157 0.87 FDPS (0.54) FDPSTNFRSF1AALDH1A1MAPK1TSHR
SCHEMBL2709918 0.87 FDPS (0.47) FDPSTNFRSF1AALDH1A1MAPK1TSHR
SCHEMBL16360706 0.86 FDPS (0.50) FDPSTNFRSF1AALDH1A1MAPK1TSHR
SCHEMBL7466433 0.86 FDPS (0.53) FDPSTNFRSF1AALDH1A1MAPK1TSHR
SCHEMBL7962228 0.84 FDPS (0.45) FDPSTNFRSF1AALDH1A1MAPK1TSHR
SCHEMBL10572490 0.84 FDPS (0.51) FDPSTNFRSF1AALDH1A1MAPK1TSHR
SCHEMBL2650280 0.84 FDPS (0.51) FDPSTNFRSF1AALDH1A1MAPK1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0071741-B1 PROCESS FOR PRODUCING 2,4-DIAMINO-(3,5-DIMETHOXY-4-METHOXY-ETHOXY-BENZYL)-PYRIMIDINE PROTER S.p.A. (IT) 1985-12-04 EP claimed
US-4485248-A Process for producing 2,4-diamino-(3,5-dimethoxy-4-methoxyethoxy-benzyl)-pyrimidine PROTER S.P.A. (IT) 1984-11-27 US claimed
EP-0071741-A1 Process for producing 2,4-diamino-(3,5-dimethoxy-4-methoxy-ethoxy-benzyl)-pyrimidine PROTER S.p.A. (IT) 1983-02-16 EP claimed
US-20130131018-A1 SUBSTITUTED ISOQUINOLINES AND THEIR USE AS TUBULIN POLYMERIZATION INHIBITORS EXONHIT S.A. (FR) 2013-05-23 US disclosed
US-20130131018-A1 SUBSTITUTED ISOQUINOLINES AND THEIR USE AS TUBULIN POLYMERIZATION INHIBITORS EXONHIT S.A. (FR) 2013-05-23 US disclosed
US-20130131018-A1 SUBSTITUTED ISOQUINOLINES AND THEIR USE AS TUBULIN POLYMERIZATION INHIBITORS EXONHIT S.A. (FR) 2013-05-23 US disclosed
EP-2576514-A1 SUBSTITUTED ISOQUINOLINES AND THEIR USE AS TUBULIN POLYMERIZATION INHIBITORS EXONHIT SA (FR) 2013-04-10 EP disclosed
WO-2011151423-A1 SUBSTITUTED ISOQUINOLINES AND THEIR USE AS TUBULIN POLYMERIZATION INHIBITORS EXONHIT S.A. (FR) 2011-12-08 WO disclosed
WO-2011151423-A1 SUBSTITUTED ISOQUINOLINES AND THEIR USE AS TUBULIN POLYMERIZATION INHIBITORS EXONHIT S.A. (FR) 2011-12-08 WO disclosed
EP-1032572-B1 PYRANONES, METHOD FOR THE PRODUCTION AND USE THEREOF SCHWABE WILLMAR GMBH & CO (DE) 2002-12-11 EP disclosed
US-6288109-B1 Pyranones, method for the production and use thereof DR. WILLMAR SCHWABE GMBH & CO. (DE) 2001-09-11 US disclosed
WO-1999025716-A9 PYRANONES, METHOD FOR THE PRODUCTION AND USE THEREOF SCHWABE WILLMAR GMBH & CO (DE) 1999-09-02 WO disclosed
WO-1999025716-A2 PYRANONES, METHOD FOR THE PRODUCTION AND USE THEREOF DR. WILLMAR SCHWABE GMBH & CO. (DE) 1999-05-27 WO disclosed
EP-0065705-B1 PROCESS FOR THE PREPARATION OF SUBSTITUTED PYRIMIDINE SIEGFRIED AKTIENGESELLSCHAFT (CH) 1986-01-02 EP disclosed
EP-0071741-B1 PROCESS FOR PRODUCING 2,4-DIAMINO-(3,5-DIMETHOXY-4-METHOXY-ETHOXY-BENZYL)-PYRIMIDINE PROTER S.p.A. (IT) 1985-12-04 EP disclosed
US-4485248-A Process for producing 2,4-diamino-(3,5-dimethoxy-4-methoxyethoxy-benzyl)-pyrimidine PROTER S.P.A. (IT) 1984-11-27 US disclosed
US-4485248-A Process for producing 2,4-diamino-(3,5-dimethoxy-4-methoxyethoxy-benzyl)-pyrimidine PROTER S.P.A. (IT) 1984-11-27 US disclosed
EP-0071741-A1 Process for producing 2,4-diamino-(3,5-dimethoxy-4-methoxy-ethoxy-benzyl)-pyrimidine PROTER S.p.A. (IT) 1983-02-16 EP disclosed
EP-0071741-A1 Process for producing 2,4-diamino-(3,5-dimethoxy-4-methoxy-ethoxy-benzyl)-pyrimidine PROTER S.p.A. (IT) 1983-02-16 EP disclosed
EP-0065705-A1 Process for the preparation of substituted pyrimidine SIEGFRIED AKTIENGESELLSCHAFT (CH) 1982-12-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130131018-A1 SUBSTITUTED ISOQUINOLINES AND THEIR USE AS TUBULIN POLYMERIZATION INHIBITORS TUBB3, TUBB, TUBB1 FDPS 1240/4885TNFRSF1A 3860/4885ALDH1A1 2257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.